Yantai Dongcheng Pharmaceutical Group Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 2,583

Employees

  • Stock Symbol
  • 002675

Stock Symbol

  • Investments
  • 14

  • Share Price
  • $1.78
  • (As of Friday Closing)

Yantai Dongcheng Pharmaceutical Group General Information

Description

Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.

Contact Information

Formerly Known As
Yantai Dongcheng Biochemicals Company
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No.7 ChangBaiShan Road
  • Yantai Development Zone
  • Yantai, Shandong 264006
  • China
+86 153
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • No.7 ChangBaiShan Road
  • Yantai Development Zone
  • Yantai, Shandong 264006
  • China
+86 153

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yantai Dongcheng Pharmaceutical Group Stock Performance

As of 20-Nov-2026, Yantai Dongcheng Pharmaceutical Group’s stock price is $1.78. Its current market cap is $1.47B with 825M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.78 $1.86 $1.76 - $2.25 $1.47B 825M 8.34M $0.04

Yantai Dongcheng Pharmaceutical Group Financials Summary

As of 30-Sep-2026, Yantai Dongcheng Pharmaceutical Group has a trailing 12-month revenue of $382M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,790,499 1,736,967 1,497,779 2,217,713
Revenue 381,998 381,164 399,826 462,997
EBITDA 55,932 75,450 66,199 72,944
Net Income 30,482 27,203 25,619 29,645
Total Assets 1,357,281 1,318,302 1,182,816 1,140,191
Total Debt 186,535 107,993 117,616 105,895
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Yantai Dongcheng Pharmaceutical Group Patents

Yantai Dongcheng Pharmaceutical Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026194083-A1 Escherichia coli for high-yield production of fructosylated chondroitin, and production method for escherichia coli Pending 18-Mar-2025
US-20260286412-A1 High-yield fructosylated chondroitin-producing escherichia coli and its application thereof Pending 18-Mar-2025
WO-2026194076-A1 Preparation method for chondroitin sulfate sodium and use thereof Pending 18-Mar-2025
US-20260286014-A1 Preparation method for sodium chondroitin sulfate and use thereof Pending 18-Mar-2025
WO-2025157248-A1 Fucosylated chondroitin sulfate oligosaccharide derivative and use thereof Pending 26-Jan-2024
To view Yantai Dongcheng Pharmaceutical Group’s complete patent history, request access »

Yantai Dongcheng Pharmaceutical Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yantai Dongcheng Pharmaceutical Group Investments & Acquisitions (14)

Yantai Dongcheng Pharmaceutical Group’s most recent deal was a Later Stage VC with Lannacheng Biotech for . The deal was made on 18-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lannacheng Biotech 18-Jul-2025 Later Stage VC Drug Discovery
Andico Pharmaceutical Group 17-May-2025 Merger/Acquisition Diagnostic Equipment
Lannacheng Biotech 14-Feb-2025 Later Stage VC Drug Discovery
Rongcheng Medical (Rights for 99mTc-GSA Injection and Cold Medicine Box) 21-Feb-2024 Corporate Asset Purchase Buildings and Property
Lannacheng Biotech 23-Jun-2023 Early Stage VC Drug Discovery
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Yantai Dongcheng Pharmaceutical Group ESG

Risk Overview

Risk Rating

Updated March, 31, 2025

40.15 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Pharmaceuticals

Subindustry

of 406

Rank

Percentile

To view Yantai Dongcheng Pharmaceutical Group’s complete esg history, request access »

Yantai Dongcheng Pharmaceutical Group Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Lannacheng Biotech Yantai, China 2021
Shanghai Yitai Pharmaceutical Technology Shanghai, China 2016
Mitro Biotech Nanjing, China 2012
Andico Pharmaceutical Group Hong Kong, Hong Kong 2009
Sino Siam Biotechnique Lopburi, Thailand 2005
You’re viewing 5 of 6 affiliates. Get the full list.  »

Yantai Dongcheng Pharmaceutical Group FAQs

  • When was Yantai Dongcheng Pharmaceutical Group founded?

    Yantai Dongcheng Pharmaceutical Group was founded in 1998.

  • Where is Yantai Dongcheng Pharmaceutical Group headquartered?

    Yantai Dongcheng Pharmaceutical Group is headquartered in Yantai, China.

  • What is the size of Yantai Dongcheng Pharmaceutical Group?

    Yantai Dongcheng Pharmaceutical Group has 2,583 total employees.

  • What industry is Yantai Dongcheng Pharmaceutical Group in?

    Yantai Dongcheng Pharmaceutical Group’s primary industry is Pharmaceuticals.

  • Is Yantai Dongcheng Pharmaceutical Group a private or public company?

    Yantai Dongcheng Pharmaceutical Group is a Public company.

  • What is Yantai Dongcheng Pharmaceutical Group’s stock symbol?

    The ticker symbol for Yantai Dongcheng Pharmaceutical Group is 002675.

  • What is the current stock price of Yantai Dongcheng Pharmaceutical Group?

    As of 20-Nov-2026 the stock price of Yantai Dongcheng Pharmaceutical Group is $1.78.

  • What is the current market cap of Yantai Dongcheng Pharmaceutical Group?

    The current market capitalization of Yantai Dongcheng Pharmaceutical Group is $1.47B.

  • What is Yantai Dongcheng Pharmaceutical Group’s current revenue?

    The trailing twelve month revenue for Yantai Dongcheng Pharmaceutical Group is $382M.

  • What is Yantai Dongcheng Pharmaceutical Group’s annual earnings per share (EPS)?

    Yantai Dongcheng Pharmaceutical Group’s EPS for 12 months was $0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process